Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitman, S. C.
Right arrow Articles by Daugherty, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitman, S. C.
Right arrow Articles by Daugherty, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 43, 1201-1208, August 2002
Copyright © 2002 by Lipid Research, Inc.

Macrophage-specific expression of class A scavenger receptors in LDL receptor-/- mice decreases atherosclerosis and changes spleen morphology

Stewart C. Whitman1,*, Debra L. Rateri*, Stephen J. Szilvassy{dagger}, Joseph A. Cornicelli§ and Alan Daugherty2,*

* Gill Heart Institute, Division of Hematology/Oncology, University of Kentucky, Lexington, KY 40536
{dagger} Division of Cardiovascular Medicine, and Blood and Marrow Transplant Program, Division of Hematology/Oncology, University of Kentucky, Lexington, KY 40536
§ Pfizer Global Research and Development, Ann Arbor Laboratories, Cardiovascular Therapeutics, 2800 Plymouth Road, Ann Arbor, MI 48105

2 To whom correspondence should be addressed. e-mail: adaugh{at}uky.edu

Class A scavenger receptors (SR-A) have been implicated in the atherogenic process, although there have been conflicting reports as to their specific effect on the development of lesions. In part, this discord may arise because of the variable contribution of SR-A in the several cell types known to express this protein. To determine the effects of macrophage-specific SR-A expression in the atherogenic process, transgenic mice were created using the chicken lysozyme (lyso) promoter to drive expression of bovine SR-A (bSR-A). To express this gene in an atherosclerosis-susceptible strain, bone marrow cells from transgenic and non-transgenic littermates were used to repopulate lethally-irradiated female LDL receptor (LDLr)-/- mice. Following hematopoietic engraftment, mice were placed on a diet enriched in saturated fat and cholesterol. After 8 weeks, there was a modest, but statistically significant reduction in serum total cholesterol in LDLr-/- mice repopulated with lyso-bSR-A transgenic cells, due to decreased LDL-cholesterol. The extent of atherosclerosis was reduced in both cross-sectional analysis of the aortic root and en face analysis of the intimal surface of the aortic arch. In addition to changes in atherosclerosis, lyso-bSR-A repopulated LDLr-/- mice had a marked increase (3.6x) in spleen weights and a disruption of spleen white pulp formation.

Therefore, macrophage-specific overexpression of SR-A resulted in reduced atherosclerosis in two vascular beds, reduced serum cholesterol concentrations, and changed the morphology of the spleen.

Abbreviations: BMT, bone marrow transplant; lyso, lysozyme; SR-A, class A scavenger receptors

Supplementary key words bone marrow transplantation • low density lipoprotein • immune function


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Han, S. Kitamoto, Q. Lian, and W. A. Boisvert
Interleukin-10 Facilitates Both Cholesterol Uptake and Efflux in Macrophages
J. Biol. Chem., November 20, 2009; 284(47): 32950 - 32958.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Gutwein, M. S. Abdel-Bakky, A. Schramme, K. Doberstein, N. Kampfer-Kolb, K. Amann, I. A. Hauser, N. Obermuller, C. Bartel, A.-A. H. Abdel-Aziz, et al.
CXCL16 Is Expressed in Podocytes and Acts as a Scavenger Receptor for Oxidized Low-Density Lipoprotein
Am. J. Pathol., June 1, 2009; 174(6): 2061 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. M. Okamura, J. M. Lopez-Guisa, K. Koelsch, S. Collins, and A. A. Eddy
Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F575 - F585.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A. Bostrom, B. B. Boyanovsky, C. T. Jordan, M. P. Wadsworth, D. J. Taatjes, F. C. de Beer, and N. R. Webb
Group V Secretory Phospholipase A2 Promotes Atherosclerosis: Evidence From Genetically Altered Mice
Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 600 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-L. Lin, W. J. S. de Villiers, B. Garvy, S. R. Post, T. R. Nagy, F. F. Safadi, M. C. Faugere, G. Wang, H. H. Malluche, and J. P. Williams
The Effect of Class A Scavenger Receptor Deficiency in Bone
J. Biol. Chem., February 16, 2007; 282(7): 4653 - 4660.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. A. Cassis, D. L. Rateri, H. Lu, and A. Daugherty
Bone Marrow Transplantation Reveals That Recipient AT1a Receptors Are Required to Initiate Angiotensin II-Induced Atherosclerosis and Aneurysms
Arterioscler Thromb Vasc Biol, February 1, 2007; 27(2): 380 - 386.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. J. Moore and M. W. Freeman
Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1702 - 1711.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Ricci, G. Sumara, I. Sumara, I. Rozenberg, M. Kurrer, A. Akhmedov, M. Hersberger, U. Eriksson, F. R. Eberli, B. Becher, et al.
Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis
Science, November 26, 2004; 306(5701): 1558 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. Whitman, D. L. Rateri, S. J. Szilvassy, W. Yokoyama, and A. Daugherty
Depletion of Natural Killer Cell Function Decreases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1049 - 1054.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement